Hideki Yokoi Selected Research

Proteinuria

5/2023	Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists.
1/2023	A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse.
1/2022	Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
1/2020	Mice lacking core 1-derived O-glycan in podocytes develop transient proteinuria, resulting in focal segmental glomerulosclerosis.
1/2020	Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
10/2018	A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
9/2017	O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
1/2017	Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
1/2017	Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis.
1/2014	Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideki Yokoi Research Topics

Disease

15	Fibrosis (Cirrhosis) 11/2023 - 05/2002
13	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 03/2003
13	Proteinuria 05/2023 - 01/2005
9	Albuminuria 01/2023 - 05/2012
7	Chronic Renal Insufficiency 05/2023 - 06/2009
7	Glomerulonephritis 01/2018 - 05/2003
5	Inflammation (Inflammations) 11/2023 - 01/2012
5	Kidney Diseases (Kidney Disease) 10/2023 - 01/2014
4	Peritoneal Fibrosis 11/2023 - 01/2012
4	Hypertension (High Blood Pressure) 10/2023 - 07/2012
4	Sclerosis 01/2020 - 07/2012
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 09/2006
3	Acute Kidney Injury (Acute Renal Failure) 05/2023 - 06/2009
3	IGA Glomerulonephritis (IGA Nephropathy) 09/2021 - 01/2018
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021 - 01/2020
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 09/2005
3	Ureteral Obstruction 01/2017 - 05/2002
2	Neoplasms (Cancer) 10/2023 - 01/2023
2	Wounds and Injuries (Trauma) 01/2023 - 11/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2005
2	Nephritis 01/2018 - 01/2017
2	Bacterial Infections (Bacterial Infection) 11/2017 - 02/2015
2	Obesity 11/2017 - 01/2014
1	Heart Failure 10/2023
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2023
1	hikikomori 01/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2023
1	Glycosuria 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Hypothermia 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Muscle Weakness 01/2021
1	Immunoglobulin Light-chain Amyloidosis 01/2021
1	Monoclonal Gammopathy of Undetermined Significance 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
10	Connective Tissue Growth FactorIBA 01/2023 - 05/2002
6	Lipocalin-2IBA 10/2023 - 02/2009
5	CreatinineIBA 10/2023 - 01/2014
5	AlbuminsIBA 02/2023 - 01/2017
4	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 11/2023 - 01/2012
4	AldosteroneIBA 10/2023 - 07/2012
4	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 09/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 11/2003
3	Natriuretic PeptidesIBA 10/2023 - 07/2012
3	SaltsIBA 01/2023 - 07/2012
3	CytokinesIBA 01/2023 - 04/2016
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 03/2003
3	Toll-Like Receptor 4IBA 01/2020 - 01/2014
3	Immunoglobulin G (IgG)IBA 10/2018 - 01/2017
3	antiglomerular basement membrane antibodyIBA 01/2018 - 01/2017
3	Extracellular Matrix ProteinsIBA 01/2017 - 01/2005
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2020
2	NPHS2 proteinIBA 01/2023 - 09/2017
2	nephrinIBA 01/2023 - 01/2019
2	Neuraminidase (Sialidase)IBA 01/2022 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2020
2	LigandsIBA 01/2020 - 01/2014
2	ChemokinesIBA 01/2018 - 04/2016
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2003
2	Serum AlbuminIBA 01/2017 - 01/2015
2	FR 167653IBA 01/2017 - 09/2005
2	Biomarkers (Surrogate Marker)IBA 05/2012 - 06/2009
2	LeptinIBA 09/2011 - 01/2005
2	anti-Thy antibodyIBA 10/2007 - 05/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2003 - 05/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	Matrix Metalloproteinases (MMPs)IBA 11/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2023
1	Atrial Natriuretic Factor (ANF)IBA 10/2023
1	ElectrolytesIBA 05/2023
1	Antineoplastic Agents (Antineoplastics)IBA 05/2023
1	TinIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	FibrinIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	InterleukinsIBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	IntegrinsIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2022
1	Dynamins (Dynamin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 09/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	Amyloidogenic ProteinsIBA 01/2021

Therapy/Procedure

5	Therapeutics 05/2017 - 01/2005
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2017
2	Peritoneal Dialysis 01/2022 - 01/2012
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2015
1	Catheters 01/2022
1	Resuscitation 01/2022
1	Rewarming 01/2022